Navigation Links
Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
Date:10/26/2010

THE WOODLANDS, Texas, Oct. 26 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that it will release its third quarter 2010 financial results on Friday, November 5, 2010 before the financial markets open.  Lexicon management will hold a conference call to discuss its clinical development progress and financial results for the quarter at 11:00 a.m. Eastern Time that same day.

The dial-in number for the conference call is 888-220-1244 (within the US/Canada) or 706-679-5615 (international).  The conference ID for all callers is 20791091.  Investors can access a live webcast of the call at www.lexpharma.com.  An archived version of the webcast will be available on the website through November 12, 2010.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, di
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
2. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results
3. Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
4. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
5. Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
6. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
7. Lexicon to Present at BIO International Convention
8. Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week
9. Lexicon Announces Proposed $95 Million Common Stock Offering
10. Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
11. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  TNI BioTech, Inc. ... company focused on the development, marketing and distribution ... filed definitive proxy materials with the Securities and ... Meeting of Shareholders to be held on Thursday, ... Time. The record date for determining those shareholders ...
(Date:7/28/2014)... ANGELES , SINGAPORE, and TOKYO , ... announced that it has appointed Roger Crystal , ... most recently served in the Global Business Development Product ... "Roger,s experience in developing business strategy and ... valuable as we continue to partner with biotechnology and ...
(Date:7/28/2014)... 28, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... its second quarter 2014 financial results for the period ended ... close. PDL,s management will host a conference call and webcast ... financial results.  A slide presentation relating to the call will ... Conference Call Details To access the live ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2
... SYDNEY, Australia, June 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis,(ASX: PXS; ... Limited to,manage and provide eligible patients worldwide with ... The program will allow patients who are unable ... are considered by their physician,to be suffering from ...
... Claims Cover Anti-Viral Applications of Novel Targeted Agents Under ... Company,s Anti-Phospholipid Technology Platform -, - Anti-Viral ... Presented at American Association of Immunologists Annual Meeting ... (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company developing ...
Cached Medicine Technology:Pharmaxis Establishes Named Patient Program for Bronchitol 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 4
(Date:7/28/2014)... Dawn Echols’ professional background spans success in ... experience has honed her people skills and led ... counseling ( http://dawningphoenix.com ) work includes private practice, ... domestic violence. , As owner and executive ... individuals and groups for a variety of disorders. ...
(Date:7/28/2014)... 2014 (HealthDay News) -- Elementary school students seem to be ... according to a new study of school officials. , , ... Agriculture -- went into effect in the fall of 2012. ... buying lunch, or throw away most of their food. But ... this isn,t the case. , , "The updated meals standards ...
(Date:7/28/2014)... 28, 2014 Ticket Down is ... tickets in Dallas, TX at the Cotton Bowl. The ... the USA and it is an eight team tourney. ... world including teams from La Liga, Serie A, English Premier ... battle it out on the pitch include: Manchester United, ...
(Date:7/28/2014)... 28, 2014 Shofner Vision Center ... June . Renowned LASIK and Cataract Surgeon, Dr. ... significant funds and public awareness for local not-for-profit ... personnel and their families. “This was our 2nd ... nearly $5,000 to a variety of local not-for-profit ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Cape ... Summit Provider Exchange technology solution in an ... efforts and support collaboration with their New Jersey ... acute-care medical center located in New Jersey, serves ... visitors with a variety of inpatient and outpatient ...
Breaking Medicine News(10 mins):Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3
... 24 For the second,consecutive year, the Ohio ... help fund dental education in Ohio., Supporting ... ODAF,funded five grants and 25 scholarships in September. ... students and 11 to dental auxiliary,students., Recipients ...
... one guy and one gal to,be selected as the ,hot ... Sept. 24 If you,ve ever been to Joe,Weider,s Olympia ... Vegas. With,the help of The Vitamin Shoppe and BodyTech.com it,s ... for two participants to,realize their dream of being a star ...
... HTH Worldwide, a global health,and safety services company, ... serve as Chief Financial Officer. Mr. Joseph joins ... company continue its history of strong and,profitable growth. ... Finance and,Accounting at Neoware, Inc., King of Prussia, ...
... 24 The Tri-Council for,Nursing is collaborating with ... study of the impact Advanced Practice Registered Nurses,(APRNs) ... first,comprehensive study of its kind in 20 years, ... by nurses in the four APRN roles --,Clinical ...
... nationwide study to explore an investigational treatment for advanced ... Trial focuses on airway bypass, a minimally invasive procedure ... breath typical complications of emphysema - by making ... , During the airway bypass procedure, new ...
... Barack,Obama and John McCain arrive in Oxford, Mississippi for ... activists from across the,country demanding that the next president ... in office., On Friday, September 26, at 3 ... will hold a demonstration and mock funeral at Oxford ...
Cached Medicine News:Health News:Ohio Dental Association Foundation Again Awards Over $60,000 in Dental Education Grants and Scholarships Across Ohio 2Health News:Who Will Be The 'Hot Bod' at the Olympia? 2Health News:HTH Worldwide Welcomes New Chief Financial Officer 2Health News:27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness 2Health News:27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness 3Health News:Potential treatment option for severe emphysema under study 2Health News:AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy 2
... , Combined Advanced Technologies, The ... technologically advanced combination of high pressure ... Proprietary coextrusion process yields a remarkably ... conventional high pressure balloon materials., Non-Compliant ...
Used retrograde to dilate the ureter and establish a conduit for a flexible ureteroscope. Supplied sterile in peel-open packages. Intended for one-time use....
... Diameter; 5.4 Fr Straight Channel; 33 or ... MRO-7 Integral Operating Ureteroscopes offer a small ... easy access to the ureter for diagnosis ... Fr) is ideal for large operating instruments, ...
... self-dilating, semi-rigid autoclavable operating ureteroscope featuring distortion-free ... for an enhanced, clear image. The universal ... diopters. The direction of view is 5 ... straight access operating channel is ideal for ...
Medicine Products: